Skip to content

DRUG

BRIGHT MINDS BIOSCIENCES INC.

NASDAQ · Healthcare · Biotechnology · CA

$60.98
−0.93%
Ask drillr

Year over year

Reported trailing growth

Revenue
EBITDA
EBIT
EPS
-77.0%
Free cash flow
Operating cash flow

Forward estimates

Based on analyst estimates

Revenue
EBITDA
EPS

Three-year CAGR

Revenue
EBITDA
EBIT
Net income
EPS
Free cash flow

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026